Inventor · disambiguated record
Changyou Zhou
Also filed as: ZHOU CHANGYOU
45 granted patents·8 pending applications·264 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
53 records- 0195US9328111B2Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitorsZHOU CHANGYOU·Filed 2011·Granted May 3, 2016·102 cites·6 claims
- 0293US10864203B2Combination of a PD-1 antagonist and a RAF inhibitor for treating cancerBEIGENE LTD·Filed 2017·Granted Dec 15, 2020·10 cites·13 claims
- 0392US11202782B2Treatment cancers using a combination comprising PARP inhibitorsBEIGENE LTD·Filed 2017·Granted Dec 21, 2021·9 cites·29 claims
- 0492US10112952B2Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitorsBEIGENE LTD·Filed 2017·Granted Oct 30, 2018·5 cites·17 claims
- 0590US9393232B2Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-onesBEIGENE LTD·Filed 2014·Granted Jul 19, 2016·15 cites·12 claims
- 0687US10501467B2Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitorsBEIGENE LTD·Filed 2018·Granted Dec 10, 2019·2 cites·17 claims
- 0787US9617273B2Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitorsBEIGENE LTD·Filed 2016·Granted Apr 11, 2017·6 cites·10 claims
- 0886US10351559B2Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and uses thereforeBEIGENE LTD·Filed 2016·Granted Jul 16, 2019·2 cites·46 claims
- 0985US10280163B25 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenasesBEIGENE LTD·Filed 2016·Granted May 7, 2019·5 cites·30 claims
- 1084US11534431B2Combination of a PD-1 antagonist and a RAF inhibitor for treating cancerBEIGENE LTD·Filed 2020·Granted Dec 27, 2022·1 cites·21 claims
- 1184US9273046B2Fused tricyclic compounds as Raf kinase inhibitorsZHOU CHANGYOU·Filed 2011·Granted Mar 1, 2016·7 cites·9 claims
- 1283US9920055B2Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitorsBEIGENE LTD·Filed 2017·Granted Mar 20, 2018·3 cites·20 claims
- 1383US9260440B2Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitorsZHOU CHANGYOU·Filed 2011·Granted Feb 16, 2016·7 cites·6 claims
- 1482US9895376B2Fused tricyclic compounds as Raf kinase inhibitorsBEIGENE LTD·Filed 2016·Granted Feb 20, 2018·3 cites·17 claims
- 1582US9670203B2Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitorsBEIGENE LTD·Filed 2014·Granted Jun 6, 2017·4 cites·24 claims
- 1681US10208038B2Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitorsBEIGENE LTD·Filed 2018·Granted Feb 19, 2019·2 cites·27 claims
- 1780US10457680B2Process for preparing a PARP inhibitor, crystalline forms, and uses thereofBEIGENE LTD·Filed 2016·Granted Oct 29, 2019·3 cites·23 claims
- 1880US7759493B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Jul 20, 2010·9 cites·20 claims
- 1979US10899763B2Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereofBEIGENE LTD·Filed 2018·Granted Jan 26, 2021·1 cites·26 claims
- 2079US10647714B25 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenasesBEIGENE LTD·Filed 2019·Granted May 12, 2020·2 cites·29 claims
- 2179US10576087B2Fused tricyclic compounds as Raf kinase inhibitorsBEIGENE LTD·Filed 2018·Granted Mar 3, 2020·2 cites·16 claims
- 2278US6812234B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Nov 2, 2004·14 cites·29 claims
- 2377US11472788B2Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenasesBEIGENE LTD·Filed 2018·Granted Oct 18, 2022·1 cites·7 claims
- 2477US10562899B2Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitorsBEIGENE LTD·Filed 2019·Granted Feb 18, 2020·1 cites·27 claims
- 2576US7247725B2Gamma-aminoamide modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Jul 24, 2007·9 cites·3 claims
- 2675US9670231B2Fused tricyclic amide compounds as multiple kinase inhibitorsBEIGENE LTD·Filed 2014·Granted Jun 6, 2017·6 cites·37 claims
- 2775US8039484B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2007·Granted Oct 18, 2011·2 cites·14 claims
- 2875US7230008B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Jun 12, 2007·5 cites·12 claims
- 2973US10882856B25 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenasesBEIGENE LTD·Filed 2017·Granted Jan 5, 2021·1 cites·33 claims
- 3072US9034851B2Substituted pyrimidinesMERCK SHARP & DOHME·Filed 2012·Granted May 19, 2015·2 cites·15 claims
- 3171US6387932B1Somatostatin agonistsMERCK & CO INC·Filed 2000·Granted May 14, 2002·7 cites·12 claims
- 3270US7786305B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2004·Granted Aug 31, 2010·4 cites·5 claims
- 3370US7390803B2Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Jun 24, 2008·5 cites·34 claims
- 3469US7393844B2Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Jul 1, 2008·4 cites·27 claims
- 3565US9079930B2Substituted pyrimidinesMERCK SHARP & DOHME·Filed 2012·Granted Jul 14, 2015·1 cites·16 claims
- 3663US2025090507A1Methods of Treating Cancer With a B-RAF InhibitorMAPKURE LLC·Filed 2024·Application pending·0 cites
- 3761US7166614B2Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2003·Granted Jan 23, 2007·1 cites·27 claims
- 3857US7361765B2Process for the preparation of CCR-2 antagonistsMERCK & CO INC·Filed 2004·Granted Apr 22, 2008·1 cites·7 claims
- 3950US2021300936A1Pyrazolotriazolopyrimidine derivatives as a2a receptor antagonistBEIGENE LTD·Filed 2019·Application pending·0 cites
- 4050US2022227762A1Amide-substituted imidazo compounds as selective inhibitors of indoleamine 2,3-dioxygenasesBEIGENE LTD·Filed 2020·Application pending·0 cites
- 4148US7598243B2Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Oct 6, 2009·0 cites·11 claims
- 4247US12281119B2Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonistBEIGENE LTD·Filed 2020·Granted Apr 22, 2025·0 cites·9 claims
- 4347US11472811B2Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonistBEIGENE LTD·Filed 2019·Granted Oct 18, 2022·0 cites·29 claims
- 4447US2007117797A1Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activityGOBLE STEPHEN D·Filed 2004·Application pending·0 cites
- 4547US2020155567A1Treatment of cancers using a combination comprising parp inhibitors, temozolomide and/or radiation therapyBEIGENE LTD·Filed 2018·Application pending·0 cites
- 4646US9827226B2Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-onesBEIGENE LTD·Filed 2016·Granted Nov 28, 2017·0 cites·11 claims
- 4746US7557120B2Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Jul 7, 2009·0 cites·15 claims
- 4845US7514431B2Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Apr 7, 2009·0 cites·22 claims
- 4942US7410961B22,6-disubstituted piperiddines as modulatorsMERCK & CO INC·Filed 2005·Granted Aug 12, 2008·0 cites·26 claims
- 5042US2010234409A1Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activityYANG LIHU·Filed 2005·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Changyou Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →